NO962424L - Nye substituerte oksazolidiner - Google Patents

Nye substituerte oksazolidiner

Info

Publication number
NO962424L
NO962424L NO962424A NO962424A NO962424L NO 962424 L NO962424 L NO 962424L NO 962424 A NO962424 A NO 962424A NO 962424 A NO962424 A NO 962424A NO 962424 L NO962424 L NO 962424L
Authority
NO
Norway
Prior art keywords
pct
date jun
sec
compounds
substituted oxazolidines
Prior art date
Application number
NO962424A
Other languages
English (en)
Other versions
NO962424D0 (no
NO306463B1 (no
Inventor
Alfred Sallmann
Hans-Peter Gschwind
Eric Francotte
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO962424L publication Critical patent/NO962424L/no
Publication of NO962424D0 publication Critical patent/NO962424D0/no
Publication of NO306463B1 publication Critical patent/NO306463B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO962424A 1993-12-10 1996-06-07 Nye substituerte oksazolidiner, farmasöytisk preparat inneholdene slike forbindelser og deres anvendelse NO306463B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH369193 1993-12-10
PCT/EP1994/003937 WO1995015953A1 (en) 1993-12-10 1994-11-28 Novel substituted oxazolidines

Publications (3)

Publication Number Publication Date
NO962424L true NO962424L (no) 1996-06-07
NO962424D0 NO962424D0 (no) 1996-06-07
NO306463B1 NO306463B1 (no) 1999-11-08

Family

ID=4261454

Family Applications (1)

Application Number Title Priority Date Filing Date
NO962424A NO306463B1 (no) 1993-12-10 1996-06-07 Nye substituerte oksazolidiner, farmasöytisk preparat inneholdene slike forbindelser og deres anvendelse

Country Status (14)

Country Link
US (1) US5635524A (no)
EP (1) EP0733047B1 (no)
JP (1) JP3792713B2 (no)
KR (1) KR100354528B1 (no)
AT (1) ATE171169T1 (no)
AU (1) AU692809B2 (no)
CA (1) CA2177171C (no)
DE (1) DE69413417T2 (no)
ES (1) ES2121621T3 (no)
FI (1) FI119987B (no)
HU (1) HU221500B (no)
NO (1) NO306463B1 (no)
NZ (1) NZ276421A (no)
WO (1) WO1995015953A1 (no)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4064257A (en) * 1976-07-19 1977-12-20 Syntex (U.S.A.) Inc. Thiazole cardiovascular agents
ZW6584A1 (en) * 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
TW209832B (no) * 1989-10-10 1993-07-21 Glaxo Group Ltd

Also Published As

Publication number Publication date
WO1995015953A1 (en) 1995-06-15
US5635524A (en) 1997-06-03
JP3792713B2 (ja) 2006-07-05
AU692809B2 (en) 1998-06-18
CA2177171C (en) 2006-01-17
HU221500B (en) 2002-10-28
EP0733047A1 (en) 1996-09-25
KR100354528B1 (ko) 2002-12-18
DE69413417T2 (de) 1999-03-04
FI962341A0 (fi) 1996-06-05
NO962424D0 (no) 1996-06-07
ATE171169T1 (de) 1998-10-15
ES2121621T3 (es) 1998-12-01
EP0733047B1 (en) 1998-09-16
NO306463B1 (no) 1999-11-08
HU9601585D0 (en) 1996-08-28
HUT74689A (en) 1997-01-28
CA2177171A1 (en) 1995-06-15
FI119987B (fi) 2009-05-29
NZ276421A (en) 1998-01-26
DE69413417D1 (de) 1998-10-22
AU1068395A (en) 1995-06-27
FI962341A (fi) 1996-06-05
JPH09506357A (ja) 1997-06-24

Similar Documents

Publication Publication Date Title
KR970704435A (ko) 헤테로시클릭 화합물의 도파민-D 리간드로서의 용도(Use of Heterocyclic Compounds as Dopamines-D Ligands)
DK0778834T3 (da) Bicykliske, heterocykliske diarylforbindelser som inhibitorer af cyclooxygenase-2
GEP20033053B (en) Substituted Pyrazoles as P38 Kinase Inhibitors, Methods for their Production, Pharmaceutical Compositions Containing Them and Methods for Treatment
NO962855L (no) Nye piperidin-derivater med PAF-antagonist-aktivitet
ATE181731T1 (de) Isothioharnstoff-derivate als no synthase hemmer
FR2549049B1 (fr) Nouvelles amidines, leur procede de preparation et leur application therapeutique
DE69512208T2 (de) Aminosäurederivate und ihre verwendung als phospholipase-a2-inhibitoren
DK0728138T3 (da) Anthracyclinderivater
NO962424L (no) Nye substituerte oksazolidiner
ES2121218T3 (es) Fenoxifenilciclopentenilhidroxiureas.
SE0104333D0 (sv) Therapeutic agents
CA2105215A1 (en) Novel oxazolidines
PT1082116E (pt) Utilizacao de derivados de 4-piperidinometanol no tratamento de desordens do neurodesenvolvimento
TH148527B (th) อนุพันธ์ไพราโซโล-ควินาโซลีน กระบวนการสำหรับการเตรียมสารนั้นและการใช้สารนั้นเป็นสารยับยั้งไคเนส

Legal Events

Date Code Title Description
MK1K Patent expired